For: | Daw MA, El-Bouzedi AA, Ahmed MO, Dau AA, Agnan MM, Drah AM. Geographic integration of hepatitis C virus: A global threat. World J Virol 2016; 5(4): 170-182 [PMID: 27878104 DOI: 10.5501/wjv.v5.i4.170] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v5/i4/170.htm |
Number | Citing Articles |
1 |
Luis Antonio Uribe‐Noguez, Alicia Ocaña‐Mondragón, José Antonio Mata‐Marín, María Elena Gómez‐Torres, Rosa María Ribas‐Aparicio, María de la Luz Martínez‐Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencing. Journal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
|
2 |
T. Semenova, B. Nemoz, V. Thibault, G. Lagathu, G. Duverlie, E. Brochot, P. Trimoulet, C. Payan, S. Vallet, C. Henquell, S. Chevaliez, M. Bouvier-Alias, S. Maylin, A-M. Roque-Afonso, L. Izquierdo, F. Lunel-Fabiani, P. Marcellin, P. Morand, V. Leroy, S. Larrat. Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study. Epidemiology and Infection 2019; 147 doi: 10.1017/S0950268819001225
|
3 |
Mohamed Ali Daw, Amina Mohamed Daw, Nadia Emhemed Mohamed Sifennasr, Aisha Draha, Ahmed Daw, Ali Daw, Mohamed Ahmed, Ebtisam Mokhtar, Abdallah El-Bouzedi, Ibrahem Daw, Samia Adam, Saed Warrag. The epidemiological characterization and geographic distribution of hepatitis D virus infection in Libya. Pan African Medical Journal 2020; 35 doi: 10.11604/pamj.2020.35.120.20055
|
4 |
Mingyang Li, Hui Zhuang, Lai Wei. How would China achieve WHO’s target of eliminating HCV by 2030?. Expert Review of Anti-infective Therapy 2019; 17(10): 763 doi: 10.1080/14787210.2019.1675509
|
5 |
Anna D. Kashnikova, Tatiana N. Bystrova, Anastasia V. Polyanina, Artem A. Zalesskikh. Genetic Monitoring as a Component of Hepatitis C Surveillance. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2022; : 76 doi: 10.35627/2219-5238/2022-30-11-76-81
|
6 |
Mohamed A. Daw, Nadia E.M. Sifennasr, Abdallah El-Bouzedi, Ali O. Daeke, Aghnyia A. Dau, Aisha M. Drah, Mohamed O. Ahmed, Mohamed M. Agnan. Epidemiology of hepatitis B virus in immigrants crossing to Europe from North and Sub-Saharan Africa. Travel Medicine and Infectious Disease 2017; 16: 59 doi: 10.1016/j.tmaid.2017.01.006
|
7 |
Christian Heuss, Paul Rothhaar, Rani Burm, Ji-Young Lee, Philipp Ralfs, Uta Haselmann, Luisa J. Ströh, Ombretta Colasanti, Cong Si Tran, Noemi Schäfer, Paul Schnitzler, Uta Merle, Ralf Bartenschlager, Arvind H. Patel, Frederik Graw, Thomas Krey, Vibor Laketa, Philip Meuleman, Volker Lohmann, Charles M. Rice. A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo. PLOS Pathogens 2022; 18(6): e1010472 doi: 10.1371/journal.ppat.1010472
|
8 |
Lyudmila I. Nikolaeva, Alexander N. Belyavtsev, Nadezhda G. Shevchenko, Maya D. Stuchinskaya, Evgeniy I. Samokhvalov, Anna V. Dedova, Georgiy V. Sapronov, Nataliya S. Shastina, Victor V. Kuprianov. The analysis of immunoreactivity of individual B-cell epitopes of hepatitis C virus <i>(Flaviviridae: Hepacivirus: Hepatitis С virus)</i> NS4a antigen. Problems of Virology 2022; 67(3): 237 doi: 10.36233/0507-4088-115
|
9 |
Nuran Karabulut, Sema Alacam, Ayfer Yolcu, Mustafa Onel, Ali Agacfidan. Distribution of Hepatitis C Virus Genotypes in Istanbul, Turkey. Indian Journal of Medical Microbiology 2018; 36(2): 192 doi: 10.4103/ijmm.IJMM_17_381
|
10 |
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa. Travel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
|
11 |
Ruijun Su, Li Dong, Yongxiang Wang, Renna Sa, Yafei Wang. Distribution of hepatitis C virus genotype and subtype between Mongolian and Han in Inner Mongolia. Medicine 2022; 101(28): e29545 doi: 10.1097/MD.0000000000029545
|
12 |
Nagehan Didem Sarı, Sevim Baltalı, İstemi Serin. Evaluation of Hepatitis C in 20 Years: A Turkish Experience. Bagcilar Medical Bulletin 2023; 8(4): 363 doi: 10.4274/BMB.galenos.2023.2023-01-07
|
13 |
Marina Barriocanal, Puri Fortes. Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01833
|
14 |
Yelena Petrosyan, John-Graydon Simmons, Erin Kelly, Curtis L Cooper. Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysis. Canadian Liver Journal 2022; 5(3): 388 doi: 10.3138/canlivj-2021-0037
|
15 |
Mohamed A. Daw, Lutfi A. Buktir Ali, Amina M. Daw, Nadia E. M. Sifennasr, Aghnyia A. Dau, Mohamed M. Agnan, Abdallah El-Bouzedi. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3471-4
|
16 |
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams framework. Health Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0436-z
|
17 |
Jing Lu, Li Zhang, Xiaoqin Xu, Yuanfang Chen, Ying Zhou, Zhi Zhang, Gengfeng Fu, Guohong Chen. Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China. Drug and Alcohol Dependence 2019; 194: 101 doi: 10.1016/j.drugalcdep.2018.09.026
|
18 |
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau. Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-2491-2
|
19 |
M.A. Wahab, A. Shehta, M. Elshoubary, A.M. Yassen, M. Elmorshedi, T. Salah, A.M. Sultan, O. Fathy, W.R. Elsarraf, U. Shiha, K. Zalata, A.N. Elghawalby, M. Eldesoky, A. Monier, R. Said, A.M. Elsabagh, M. Ali, A. Kandeel, U. Abdalla, M. Aboelella, M. Elsadany, E.E. Abdel-Khalek, A. Marwan, F.M. ElMorsi, R. Adly. Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center. Transplantation Proceedings 2018; 50(5): 1396 doi: 10.1016/j.transproceed.2018.02.085
|
20 |
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in Egypt. Diagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
|
21 |
|
22 |
Mohamed A. Daw. The Epidemiology of Hepatitis C virus infection in African immigrants; bridging the gaps. Travel Medicine and Infectious Disease 2019; 27: 130 doi: 10.1016/j.tmaid.2018.05.012
|
23 |
Juan Carlos Restrepo-Gutiérrez. Una visión integral del manejo de la hepatitis C y el objetivo de erradicarla. Hepatología 2024; 5(2): 120 doi: 10.59093/27112330.114
|
24 |
Manousos E. Kambouris, Yiannis Manoussopoulos, Aristea Velegraki. Genomics in Biosecurity. 2022; : 61 doi: 10.1016/B978-0-323-85236-4.00013-3
|
25 |
Jin Yang, Yunquan Zhang, Lisha Luo, Runtang Meng, Chuanhua Yu. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis. International Journal of Environmental Research and Public Health 2018; 15(1): 170 doi: 10.3390/ijerph15010170
|